J. Daniel O'connor

Affiliations

  • Director at Diamedica Therapeutics Inc. (DMAC), 2025-02-24
  • President And Ceo at Ambrx Biopharma Inc. (AMAM), 2024-03-07
  • Director at Seelos Therapeutics Inc. (SEEL), 2024-01-09
  • President And Ceo at Ambrx Biopharma Inc. (AMAM), 2023-07-07
  • Large Shareholder, Director at Zyversa Therapeutics Inc. (ZVSA), 2022-12-15
  • Ceo And President at Oncosec Medical Inc (ONCS), 2021-05-04
  • Chief Executive Officer at Advaxis Inc. (ADXS), 2017-07-03
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SEEL $0.61 16,000 $9,788.80 16,000 2022-06-01 Filing
ONCS $0.91 10,000 $9,100.00 26,667 2018-11-07 Filing
ONCS $1.50 16,667 $25,000.50 16,667 2018-02-05 Filing
ADXS $3.00 3,333 $9,999.00 311,016 2014-03-31 Filing
ADXS $4.00 13,500 $54,000.00 61,336 2013-10-24 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AMAM $9.82 50,012 $491,117.84 342,845 2023-10-27 Filing
ONCS $4.86 3,172 $15,415.92 96,097 2021-04-30 Filing
ONCS $7.71 3,413 $26,314.23 99,269 2021-02-01 Filing
ONCS $3.79 3,280 $12,431.20 102,682 2020-11-02 Filing
ONCS $4.20 3,133 $13,158.60 105,962 2020-07-31 Filing